【结 构 式】 |
【分子编号】12515 【品名】6-Hydroxy-2-naphthalenecarboximidamide 【CA登记号】 |
【 分 子 式 】C11H10N2O 【 分 子 量 】186.21328 【元素组成】C 70.95% H 5.41% N 15.04% O 8.59% |
与该中间体有关的原料药合成路线共 2 条
合成路线1
该中间体在本合成路线中的序号:(II)This compound can be prepared by condensation of 4-guanidinobenzoic acid (I) with 6-amidino-2-naphthol (II) in pyridine either by means of DCC or the acid chloride of (I), (III), at room temperature.
【1】 Fujii, S.; Okutome, T.; Nakayama, T.; Yaegashi, T.; Kurumi, M. (Torii Pharmaceutical Co., Ltd.); Amidine compound. JP 82179146; JP 8253454; US 4454338 . |
【2】 Aoyama, T.; Nafamstat Mesylate. Drugs Fut 1984, 9, 10, 747. |
合成路线2
该中间体在本合成路线中的序号:(II)Esterification of 4-(4,5-dihydro-1H-imidazol-2-ylamino)benzoic acid methanesulfonate (I) with 6-amidino-2-naphthol methanesulfonate (II) by means of dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC) in dry pyridine.
【1】 Graul, A.; Leeson, P.; Castaner, J.; Sepimostat Mesylate. Drugs Fut 1997, 22, 5, 502. |
【2】 Fujii, S.; Okutome, T.; Nakayama, T.; Nunomura, S.; Sudo, K.; Watanabe, S.; Kurumi, M.; Aoyama, T. (Torii Pharmaceutical Co., Ltd.); Novel amidine cpds. AU 8545492; EP 0190356; ES 8607218; US 4777182; US 4820730; WO 8600893 . |
【3】 Nakayama, T.; Ikeda, M.; Taira, S.; Ashizawa, H.; Oda, M.; Fujii, S.; Arakawa, K.; Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate. Chem Pharm Bull 1993, 41, 1, 117-25. |
Extended Information